Beacon Pointe Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $328K | Sell |
8,554
-2,701
| -24% | -$104K | ﹤0.01% | 999 |
|
|
2025
Q1 | $436K | Buy |
11,255
+2,436
| +28% | +$94.4K | ﹤0.01% | 878 |
|
|
2024
Q4 | $298K | Sell |
8,819
-3,590
| -29% | -$121K | ﹤0.01% | 997 |
|
|
2024
Q3 | $507K | Buy |
12,409
+1,897
| +18% | +$77.5K | 0.01% | 843 |
|
|
2024
Q2 | $405K | Buy |
10,512
+203
| +2% | +$7.82K | ﹤0.01% | 930 |
|
|
2024
Q1 | $442K | Sell |
10,309
-3,446
| -25% | -$148K | ﹤0.01% | 949 |
|
|
2023
Q4 | $510K | Sell |
13,755
-1,584
| -10% | -$58.7K | 0.01% | 887 |
|
|
2023
Q3 | $556K | Buy |
15,339
+1,612
| +12% | +$58.4K | 0.01% | 829 |
|
|
2023
Q2 | $489K | Sell |
13,727
-2,419
| -15% | -$86.2K | 0.01% | 711 |
|
|
2023
Q1 | $574K | Buy |
16,146
+3,691
| +30% | +$131K | 0.01% | 716 |
|
|
2022
Q4 | $438K | Buy |
12,455
+3,335
| +37% | +$117K | 0.01% | 739 |
|
|
2022
Q3 | $269K | Buy |
+9,120
| New | +$269K | 0.01% | 832 |
|
|
2022
Q2 | – | Sell |
-33,431
| Closed | -$1.82M | – | 1118 |
|
|
2022
Q1 | $1.82M | Buy |
33,431
+18,774
| +128% | +$1.02M | 0.03% | 469 |
|
|
2021
Q4 | $808K | Buy |
14,657
+10,455
| +249% | +$576K | 0.02% | 424 |
|
|
2021
Q3 | $201K | Sell |
4,202
-17,287
| -80% | -$827K | 0.01% | 860 |
|
|
2021
Q2 | $1.07M | Buy |
+21,489
| New | +$1.07M | 0.04% | 328 |
|
|
2021
Q1 | – | Sell |
-15,730
| Closed | -$725K | – | 547 |
|
|
2020
Q4 | $725K | Buy |
15,730
+10,873
| +224% | +$501K | 0.05% | 231 |
|
|
2020
Q3 | $229K | Sell |
4,857
-3,675
| -43% | -$173K | 0.02% | 346 |
|
|
2020
Q2 | $435K | Buy |
+8,532
| New | +$435K | 0.04% | 253 |
|
|
2020
Q1 | – | Sell |
-3,710
| Closed | -$217K | – | 301 |
|
|
2019
Q4 | $217K | Buy |
+3,710
| New | +$217K | 0.07% | 207 |
|